Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Profound Medical (PROF) Non Operating Investment Income (2019 - 2023)

Profound Medical has reported Non Operating Investment Income over the past 5 years, most recently at $353000.0 for Q2 2023.

  • For Q2 2023, Non Operating Investment Income rose 3041.67% year-over-year to $353000.0; the TTM value through Sep 2023 reached $176000.0, down 5.88%, while the annual FY2020 figure was $237000.0, 100.85% up from the prior year.
  • Non Operating Investment Income for Q2 2023 was $353000.0 at Profound Medical, up from -$121000.0 in the prior quarter.
  • Over five years, Non Operating Investment Income peaked at $353000.0 in Q2 2023 and troughed at -$170000.0 in Q2 2021.
  • A 5-year average of $55858.1 and a median of $14105.0 in 2020 define the central range for Non Operating Investment Income.
  • Biggest five-year swings in Non Operating Investment Income: skyrocketed 7968.98% in 2020 and later tumbled 466.67% in 2022.
  • Year by year, Non Operating Investment Income stood at $118000.0 in 2019, then skyrocketed by 100.85% to $237000.0 in 2020, then skyrocketed by 40.08% to $332000.0 in 2021, then plummeted by 116.87% to -$56000.0 in 2022, then soared by 730.36% to $353000.0 in 2023.
  • Business Quant data shows Non Operating Investment Income for PROF at $353000.0 in Q2 2023, -$121000.0 in Q1 2023, and -$56000.0 in Q3 2022.